Evidence map›Paper›PMID 35057737›Full record

ArticleBMC bioinformatics2022

Drug-target interaction prediction via multiple classification strategies.

Qing Ye, Xiaolong Zhang, Xiaoli Lin

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Qing YeHubei Key Laboratory of Intelligent Information Processing and Real-Time Industrial System, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.
Xiaolong ZhangHubei Key Laboratory of Intelligent Information Processing and Real-Time Industrial System, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China. xiaolong.zhang@wust.edu.cn.ORCID http://orcid.org/0000-0001-5615-2044
Xiaoli LinHubei Key Laboratory of Intelligent Information Processing and Real-Time Industrial System, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.
Wuhan University of Science and Technology · CN

Funding

National Natural Science Foundation of China 61502356National Natural Science Foundation of China 61972299Natural Science Foundation of Hubei Province 2018CFB526Natural Science Foundation of Zhejiang Province LQ18F020006
6 · The paper itself

Abstract

backgroundComputational prediction of the interaction between drugs and protein targets is very important for the new drug discovery, as the experimental determination of drug-target interaction (DTI) is expensive and time-consuming. However, different protein targets are with very different numbers of interactions. Specifically, most interactions focus on only a few targets. As a result, targets with larger numbers of interactions could own enough positive samples for predicting their interactions but the positive samples for targets with smaller numbers of interactions could be not enough. Only using a classification strategy may not be able to deal with the above two cases at the same time. To overcome the above problem, in this paper, a drug-target interaction prediction method based on multiple classification strategies (MCSDTI) is proposed. In MCSDTI, targets are firstly divided into two parts according to the number of interactions of the targets, where one part contains targets with smaller numbers of interactions (TWSNI) and another part contains targets with larger numbers of interactions (TWLNI). And then different classification strategies are respectively designed for TWSNI and TWLNI to predict the interaction. Furthermore, TWSNI and TWLNI are evaluated independently, which can overcome the problem that result could be mainly determined by targets with large numbers of interactions when all targets are evaluated together.

resultsWe propose a new drug-target interaction (MCSDTI) prediction method, which uses multiple classification strategies. MCSDTI is tested on five DTI datasets, such as nuclear receptors (NR), ion channels (IC), G protein coupled receptors (GPCR), enzymes (E), and drug bank (DB). Experiments show that the AUCs of our method are respectively 3.31%, 1.27%, 2.02%, 2.02% and 1.04% higher than that of the second best methods on NR, IC, GPCR and E for TWLNI; And AUCs of our method are respectively 1.00%, 3.20% and 2.70% higher than the second best methods on NR, IC, and E for TWSNI.

conclusionMCSDTI is a competitive method compared to the previous methods for all target parts on most datasets, which administrates that different classification strategies for different target parts is an effective way to improve the effectiveness of DTI prediction.

Indexed as

Drug DevelopmentPharmaceutical PreparationsDrug DiscoveryDrug InteractionsReceptors, Cytoplasmic and NuclearPharmaceutical PreparationsReceptors, Cytoplasmic and NuclearDrug–target interactionMultiple classification strategiesWithin-class imbalance

Identifiers

PMID35057737
PMCPMC8772044
OpenAlexW4205676409

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.